AHCC plus vitamin C is used for clinical therapies by Medinstitute / Nikolenko Clinic – the largest clinic for functional medicine in Mediterranean regionSHOP AHCC
New study presented at a medical conference in Japan shows daily doze of AHCC reduced inflammation improved symptoms of Lyme disease patients after 8 weeks of treatment
Beaverton, OR (August 31, 2017) — A pilot human clinical study on the potential benefit of mushroom extract AHCC for patients with Lyme disease was presented at the annual International Congress on Nutrition and Integrative Medicine (ICNIM), held July 7-8 in Sapporo, Japan. The study, conducted at the Salerno Center for Complementary Medicine in New York City followed 12 patients with a definitive diagnosis of Lyme, all of whom took AHCC – an immunomodulatory nutraceutical ingredient produced from the cultured mycelia of Japanese medicinal mushrooms. The study was funded by the AHCC Research Association.
After 8 weeks of supplementation, patients experienced a significant reduction in inflammation as measured by two separate blood tests (ESR and Interleukin-8). 11 of the 12 patients experienced an amelioration of flu-like symptoms and 10 patients experienced less joint and muscle manifestations. All three patients who tested positive for serum IgM antibodies at baseline were negative following treatment.
“Inflammation is what makes Lyme Disease so debilitating” says Dr. John Salerno, the study’s Principal Investigator and head of Salerno Center for Complementary Medicine. “The fact that AHCC could reduce inflammation and improve Lyme symptoms is a truly exciting finding.”
The disease is caused by the bacterium Borrelia burgdorferi and is transmitted to humans through the bite of an infected tick. Typical symptoms include fever, headache, fatigue, a skin rash, facial paralysis, and arthritis. If left untreated, infection can spread to the joints, heart, and nervous system.
While long-term antibiotics have effectively treated Lyme disease, they must be used immediately post-infection. In many cases, Lyme is not diagnosed until much later on and many patients suffer from chronic Lyme all their lives. Reducing symptoms and improving the quality of life of those patients is a key priority for the medical community, particular as the incidence of the disease continues to rise at a rapid rate.
“While we only completed a small pilot study, there are more than 20 human clinical studies on other immune-related indications of AHCC and it has been shown to be a very safe product” says Dr. Salerno. “Therefore, AHCC should be considered by anyone who has contracted a virus or is suffering from chronic Lyme disease.”
AHCC is a natural immune-modulating compound derived from a unique fraction of specially-cultured medicinal mushroom mycelia, which has been clinically shown to strengthen the body’s immune system. One of the world’s most researched immune supplements, AHCC is currently used by more than 1,000 health care facilities worldwide to reduce incidence of infection in both healthy and immune-compromised patients. AHCC has been clinically shown to control a number of different infections including the Human Papilloma Virus (HPV) and Hepatitis C. Animal studies have shown that mice supplemented with AHCC had improved survival rates when infected with West Nile, Bird Flu, MRSA and Influenza viruses.
Studies indicate that AHCC works as an immunotherapy by using the body’s own immune system to help fight disease. Human and animal studies have shown that AHCC increases the number and/or activity of natural killer (NK) cells, killer T-cells, dendritic cells, and cytokines, which enable the body to effectively respond to infections.
AHCC is supported by more than 20 human clinical studies and more than 50 papers in PubMed-indexed journals.
The above info is also available on AHCC Research Association web page (https://www.ahccresearch.org)SHOP AHCC
Willing to analyse your immune system?
Bioresonance Cyprus Health Analysis Non-invasive Scan in 30 minsClick Here
How is AHCC Researched and Tested?
AHCC has undergone extensive research and testing in pre-clinical, in vitro, and human clinical studies.
AHCC is a functional food that is derived from healing mushrooms. AHCC is clinically tested and proven to support improved immune system health. AHCC has been studied extensively for over 20 years.
For healthy people, AHCC is useful in health maintenance and in preventing infection by aiding in the normal function of your immune system.
In integrative oncology, research indicates that AHCC may lead to longer post-operative survival, help support patients through chemotherapy, reduce the negative effects of chemotherapy and radiation, and lead to an improvement in quality of life.
AHCC is a focus of research at prestigious institutions through-out the world. AHCC has been the subject of over 100 published papers, including 30 human clinical studies.
PRE-CLINICAL AND IN VITRO STUDIES ABOUT AHCC
The Pre-Clinical and In Vitro Studies page is your direct resource and access point for all pre-clinical and in vitro studies done about AHCC.
The following pre-clinical and in vitro studies about AHCC have been completed:
- Pre-Clinical and In Vitro Studies – Cancer
AHCC has been used with great success in cancer patients. Data from the treatment of over 100,000 individuals with various types of cancer have shown AHCC treatment to be of benefit in 60% of cases.
- Pre-Clinical and In Vitro Studies – Chemo Side Effects
For many cancer patients, the impacts of chemotherapy can be very challenging and impact patient ability to recover from cancer. Learn more about how AHCC has been studied and researched with respect to its impacts on chemotherapy side effects.
- Pre-Clinical and In Vitro Studies – Liver
Learn more about how AHCC has been studied and researched with respect to its impacts on liver disease, including hepatitis.
- Pre-Clinical and In Vitro Studies – Infection
Infection can be devastating for the immune system and overall health and wellness. As a result, we’ve heavily studied the impacts AHCC has on the ability to recover from and defend against infection.
- Pre-Clinical and In Vitro Studies – Other
Learn more about AHCC studies and research related to a range of conditions and diseases. For example, learn how AHCC has been researched as an anti-inflammatory, how it may prevent and treat Diabetes, and about the recent progress of research on AHCC.
HUMAN CLINICAL STUDIES ABOUT AHCC
The Human Clinical Studies page gives you direct access to the clinical studies completed about AHCC and its effectiveness.
The following human clinical studies about AHCC have been completed:
- Human Clinical Studies – Cancer
AHCC has been used with great success in cancer patients. Data from the treatment of over 100,000 individuals with various types of cancer have shown AHCC treatment to be of benefit in 60% of cases.Learn more about how AHCC has been studied and researched with respect to its impacts on cancer treatment, recovery from specific cancer types, and immune system response.
- Human Clinical Studies – Chemo Side Effects
For many cancer patients, the impacts of chemotherapy can be very challenging and impact patient ability to recover from cancer. Learn more about how AHCC has been studied and researched with respect to its impacts on patient ability to manage and mitigate chemotherapy side effects.
- Human Clinical Studies – Liver
Learn more about how AHCC has been studied and researched with respect to its impacts on liver disease, including hepatitis, and alcohol-induced liver enzyme elevation.
- Human Clinical Studies – Healthy Adults
AHCC is not just for people dealing with illness or disease. Learn more about how AHCC has been researched with respect to its impacts on healthy individuals, including immune response to influenza vaccines and on people aged 50 years or older.
- Human Clinical Studies – Safety
The safety of any dietary supplement should be top-of-mind. Learn more about how AHCC has been studied and researched with respect to its safety for all types of individuals, including HPV-positive women, healthy individuals, and pharmacoresistant epilepsy patients.
YOU AND AHCC
We want you to know what we know about AHCC. This is why we urge you to download the research papers, to watch videos about AHCC, and to read our blog where we post articles about AHCC and your immune system health.
Contact us on your Lyme or Lyme-like disease through this form:
Medinstitute/Nikolenko Clinic working hours: Monday, Tuesday, Wednesday and Friday 8:30 – 13:00 / 15:30 – 20:00 Thursday and Saturday 8:30 – 13:00 Sunday Closed13-15, DIGENI AKRITA, NICOSIA, 1055, CYPRUS